Literature DB >> 6345754

Studies on the transport of enkephalin-like oligopeptides in rat intestinal mucosa.

G A Kerchner, L E Geary.   

Abstract

Transport of [D-Ala2, D-Leu5]enkephalin (DADLE(], Tyr-D-Ala-Gly-Phe (TDAGP) and tyrosine into rat jejunum mucosal cells was investigated in vitro. Active transport of either the pentapeptide (DADLE) or the tetrapeptide (TDAGP) into jejunal villi was not detected. Because substantial degradation of these peptides occurred during incubation, the proteolytic enzyme inhibitors, bestatin (30 microM) or D-phenylalanine (20 mM), were added during uptake studies of DADLE or TDAGP, respectively. The presence of these inhibitors significantly reduced degradation of the oligopeptides; however, no accumulation of peptides occurred in the mucosal tissue. Tyrosine was actively transported by the jejunum mucosal cells demonstrating the viability of the transport mechanisms of this in vitro preparation. The results suggest that there are no active transport systems for enkephalin-like oligopeptides.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345754

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  Differences in transport rate of oxytocin and vasopressin analogues across proximal and distal isolated segments of the small intestine of the rat.

Authors:  S Lundin; N Pantzar; A Broeders; M Ohlin; B R Weström
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

2.  Development of novel lipophilic derivatives of DADLE (leucine enkephalin analogue): intestinal permeability characateristics of DADLE derivatives in rats.

Authors:  T Uchiyama; A Kotani; H Tatsumi; T Kishida; A Okamoto; N Okada; M Murakami; T Fujita; Y Fujiwara; Y Kiso; S Muranishi; A Yamamoto
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

3.  Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.

Authors:  D I Friedman; G L Amidon
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.